Brief: Aytu Biopharma Announces Approval Of Adzenys Xr-Odt Manufacturing Site Transfer

Aytu Biopharma

27/04/2023 14:23

April 27 (Reuters) - Aytu Biopharma Inc  AYTU.O :
    * AYTU BIOPHARMA ANNOUNCES APPROVAL OF ADZENYS XR-ODT
MANUFACTURING SITE TRANSFER
    * AYTU BIOPHARMA INC - U.S. FDA APPROVAL OF PRIOR APPROVAL
SUPPLEMENT ENABLES TRANSFER OF ADZENYS PRODUCTION TO CONTRACT
MANUFACTURER IN 2023
    * AYTU BIOPHARMA INC - UPON COMPLETION OF MANUFACTURING
TRANSFER
OF ADZENYS XR-ODT AND COTEMPLA XR-ODT, EXPECTS TO IMPROVE ADHD
PRODUCT MARGINS BY 15%

Source text for Eikon:  ID: 
Further company coverage:  AYTU.O 

 ((Reuters.Briefs@thomsonreuters.com;))